Cognitive function in type 2 diabetes mellitus patients (Paperback)

Anand Vijayakumar Palur Ramakrishnan

ISBN 10: 620841783X / ISBN 13: 9786208417833

Published by LAP Lambert Academic Publishing, 2024

About this Item

Paperback. Cognitive dysfunction in type 2 diabetes mellitus is associated with decrease in psychomotor speed, frontal lobe/executive function, verbal memory, processing speed, complex motor functioning, working memory, immediate recall. Although, type 2 diabetes is associated with several other vascular risk factors of dementia, diabetes itself has been implicated as an independent risk factor for cognitive impairment and dementia. The design was a prospective observation study to assess the cognitive function of diabetic patients treated with various classes of oral hypoglycemic with or without co-morbidities in various hospitals in Nilgiris and various tertiary health centers, Coimbatore. 400 patients were screened out of which 325 patients fulfilled the inclusion and exclusion criteria. The present study showed the patients taking dipeptidyl peptidase-4 inhibitors along with metformin showed a better global cognitive score than patients taking alpha glucosidase inhibitors, thiazolidinediones or sulphonylureas along with metformin. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Seller Inventory # 9786208417833

Bibliographic Details

• Title: Cognitive function in type 2 diabetes mellitus patients (Paperback)
• Publisher: LAP Lambert Academic Publishing
• Publication Date: 2024
• Language: English
• ISBN 10: 620841783X
• ISBN 13: 9786208417833
• Binding: Paperback
• Condition: new

About this title

Synopsis

Cognitive dysfunction in type 2 diabetes mellitus is associated with decrease in psychomotor speed, frontal lobe/executive function, verbal memory, processing speed, complex motor functioning, working memory, immediate recall. Although, type 2 diabetes is associated with several other vascular risk factors of dementia, diabetes itself has been implicated as an independent risk factor for cognitive impairment and dementia. The design was a prospective observation study to assess the cognitive function of diabetic patients treated with various classes of oral hypoglycemic with or without co-morbidities in various hospitals in Nilgiris and various tertiary health centers, Coimbatore. 400 patients were screened out of which 325 patients fulfilled the inclusion and exclusion criteria. The present study showed the patients taking dipeptidyl peptidase-4 inhibitors along with metformin showed a better global cognitive score than patients taking alpha glucosidase inhibitors, thiazolidinediones or sulphonylureas along with metformin.